Influenza vaccine effective in young children

By Megan Rauscher

NEW YORK (Reuters Health) - Even in an influenza season where there is not an optimal match between circulating strains of influenza and the strains contained in the influenza vaccine, the vaccine is likely to significantly protect young children, ages 6 to 59 months, against influenza, new research indicates.

Influenza vaccine effectiveness has not been well characterized in this age group and can vary from season to season, the research team notes in the November issue of Pediatrics.

To investigate, Katherine W. Eisenberg from the University of Rochester, New York, and colleagues conducted a study of children treated for an acute respiratory infection during the 2003-2004 and 2004-2005 influenza seasons. The 288 children with laboratory-confirmed influenza were the cases; and the 744 children who tested negative served as controls.

“There was an almost 60-percent reduction in influenza-related medical visits among 6- to 59-month-old children who received all recommended doses of the influenza vaccine compared to unvaccinated children in one of the two influenza seasons we studied (2004-2005),” Eisenberg, currently in year 6 of an MD/PhD program at the University of Rochester, told Reuters Health.

In the 2003-2004 season, there was a 44-percent reduction in influenza-related medical visits, which is “consistent with vaccine effectiveness that year, although this finding was not statistically significant,” Eisenberg noted.

In the 2003-2004 season, she explained, relatively few children were vaccinated because the formal recommendation for vaccination of healthy children in this age group was not in place until the following year. “This limited our ability to detect the effectiveness of the vaccine,” Eisenberg said.

“We did not find any protection against flu for children who needed two vaccine doses and only received one,” she also noted.

These findings on influenza vaccine effectiveness in this age group are important, the researcher said, “because the match between the influenza strains in the flu vaccine and the strains circulating in the community was suboptimal in the years we studied, and we still found that the vaccine was 57-percent effective at preventing influenza-related medical visits in our study population in one of the two seasons. In a year with a better match, the potential for a reduction of illness is even greater.”

The message for parents, Eisenberg added, is that “it is important to have young children vaccinated against the flu, even in a year when the vaccine and circulating flu strains may not match perfectly.”

“Children 6 months up to 9 years of age need to have two vaccine doses if they are getting a flu vaccine for the first time,” she stressed, “Otherwise they may have reduced or no protection against the flu.”

SOURCE: Pediatrics, November 2008.


Related Posts:

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - A common strain of influenza circulating in the United States this winter is resistant to Tamiflu, the most popular drug used to treat it, federal health officials said on Friday. The situation poses little danger, according to the U.S. Centers for Disease Control and Prevention, because Tamiflu

Full Post: U.S. flu shows resistance to flu drug, CDC says

By Will Dunham WASHINGTON (Reuters) - A half dose of flu vaccine may work just as well as the full dose for healthy adults under 50 — a finding that could help stretch supplies in the event of a future vaccine shortage, researchers said on Monday. The study involved about 1,100 U.S. adults, about half of whom

Full Post: Flu shot half dose just as good for younger adults

NEW YORK (Reuters Health) - A vaccine to protect against infection with the bird flu virus, the pathogen experts fear is capable of causing pandemic disease in humans, proved safe and effective in a preliminary clinical trial with children, mirroring the results of a recent trial conducted in adults, Hungarian researchers report in the Pediatric

Full Post: Bird flu vaccine protects children

LONDON (Reuters) - A study of Merck & Co Inc’s cervical cancer vaccine Gardasil found that allergic reactions were uncommon and most young women can tolerate subsequent doses, Australian researchers said on Wednesday. The research involved 25 Australian girls with suspected hypersensitivity to the vaccine which was administered as part of a national immunization program to

Full Post: Allergic reactions to Gardasil uncommon: study

By Julie Steenhuysen CHICAGO (Reuters) - A routine childhood vaccine used to prevent several common types of infections has helped cut the rate of a deadly form of meningitis by 30 percent in children and adults, U.S. researchers said on Wednesday, suggesting even the unvaccinated are benefiting from the shot. They said the vaccine Prevnar made by

Full Post: Vaccine cuts meningitis rates, even in adults

Site Navigation

Most Read